From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Topics>
  3. Lipid Management>
  4. Archives

Lipid Management: Archives

Some content may require paid access to the site. Subscribe or purchase a seven-day site pass for the full text of all our clinical perspectives on medical journal articles, guidelines, and news.

Items 1-25 of 357 are shown

Targeting High-Dose Statins in Patients with Stable Angina

A rule based on 13 clinical factors identified patients at low or high risk for adverse vascular events.

Atorvastatin, Rosuvastatin, and Simvastatin Are Associated with Excess Risk for Diabetes

Using low doses of these drugs might mitigate the risk.

When Should CV Risk Be Remeasured in People at Low or Intermediate Risk?

Few people whose baseline cardiovascular risk was very low or low became high risk after 8 years.

Genetic Cascade Screening for Familial Hypercholesterolemia

A population-based study suggests a polygenic cause for FH in many mutation-negative patients, which may reduce the need for genetic screening of relatives.

High-Potency Statins Associated with Acute Kidney Injury

Risk is greatest during the first 4 months of treatment.

Vascular Changes During the Menopausal Transition

Adverse carotid artery remodeling accelerates during late perimenopause.

Lifting the Taboo on Eggs

Meta-analysis shows little association between egg consumption and coronary heart disease or stroke.

Another Inflammatory Disease Linked to Thrombosis?

Dermatomyositis may be associated with increased risk for cardiovascular and cerebrovascular events, but sketchy data preclude a definitive conclusion.

Pravastatin in Pregnancy? Stay Tuned.

A potential strategy for preventing preeclampsia

In Patients with Hyperlipidemia, Exercise and Statins Both Lengthen Life

Moderate fitness or statin use led to about the same 10-year mortality.

A Hat Trick for a New Type of LDL-Lowering Agent

In three separate phase II trials, a proprotein convertase subtilisin/kexin type 9 protease inhibitor achieves significant reductions in LDL levels compared with placebo or ezetimibe.

Guidelines for the Management of Stable Ischemic Heart Disease

  • Cardiology
  • Clinical Practice Guideline Watch
  • Free

New recommendations inform treatment strategies that balance life-saving interventions with symptom relief.

Statins as Anticancer Drugs?

In an observational study with limitations, statin use by cancer patients was associated with lower 3-year mortality.

Fibrates Improved Cholesterol Levels in Patients with Chronic Kidney Disease

But rising serum creatinine levels and decreasing glomerular filtration rate also were noted in a meta-analysis.

Lower LDL Cholesterol Level and Risk for CHD Later in Life

Coronary heart disease in midlife was uncommon in people with genetically low LDL cholesterol levels.

Dalcetrapib's Downfall: A Class Struggle?

Another cholesteryl ester transfer protein inhibitor raises HDL levels but fails to improve outcomes.

Calculating Patients' Lifetime Risk for Cardiovascular Disease

Is it more practical than the 10-year risk estimates we're accustomed to using?

Progress in Lipid Management

U.S. data reveal continuous improvement in population-wide lipid levels over the past 20 years.

Overweight and Obese Children Have Excess CV Risk

Meta-analysis reveals associations between high body-mass index and multiple adverse cardiovascular risk factors.

Subclinical Cardiovascular Disease Is Frequent in Patients with Severe Psoriasis

Early-onset, diffuse arterial atherosclerosis in coronary and carotid arteries was evident in these patients.

Herpes Zoster Roster

Investigators explore the degree to which chronic medical conditions affect the unexplained burden of herpes zoster.

Reducing Co-pays for Cardiovascular Meds: More Bang for the Buck?

Cutting co-payments for statins and clopidogrel was associated with improvements in adherence and resource utilization but no change in overall spending.

Biologics and Methotrexate Lower Rates of Cardiovascular Death, Myocardial Infarction, and Stroke in Patients with Severe Psoriasis

Results suggest that systemic inflammation is an important link between psoriasis and cardiovascular disease.

CRP, Fibrinogen, and Cardiac Risk Stratification

Both biomarkers slightly improved prediction when added to a base model, but their comparative clinical value has yet to be determined.

New JUPITER Analysis Clarifies Risk for Incident Diabetes with Statin Therapy

Benefits probably outweigh harms, even in patients with diabetes risk factors.

Items 1-25 of 357 are shown

Search

Advanced

Sign-In

Forgot your password? Login via Athens
or your institution

New to Journal Watch?





Copyright © 2013. Massachusetts Medical Society. All rights reserved.